Total Payments
$272,905
2024 Payments
$36,487
Companies
79
Transactions
2,219
Medicare Patients
4,640
Medicare Billing
$651,136
Payment Breakdown by Category
Other$196,437 (72.0%)
Food & Beverage$38,024 (13.9%)
Travel$20,122 (7.4%)
Consulting$18,000 (6.6%)
Education$321.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $196,437 | 115 | 72.0% |
| Food and Beverage | $38,024 | 2,010 | 13.9% |
| Travel and Lodging | $20,122 | 77 | 7.4% |
| Consulting Fee | $18,000 | 11 | 6.6% |
| Education | $321.31 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $74,535 | 214 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $60,522 | 257 | $0 (2024) |
| ABBVIE INC. | $46,970 | 142 | $0 (2024) |
| Acorda Therapeutics, Inc | $31,865 | 70 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $30,785 | 218 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $4,378 | 19 | $0 (2019) |
| GENZYME CORPORATION | $3,000 | 110 | $0 (2024) |
| Biogen, Inc. | $1,399 | 89 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,145 | 105 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,083 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,487 | 257 | ACADIA Pharmaceuticals Inc ($25,218) |
| 2023 | $56,828 | 302 | ACADIA Pharmaceuticals Inc ($33,442) |
| 2022 | $23,171 | 283 | ABBVIE INC. ($18,864) |
| 2021 | $26,031 | 260 | Allergan, Inc. ($18,209) |
| 2020 | $22,699 | 234 | Allergan, Inc. ($11,557) |
| 2019 | $49,355 | 305 | Acorda Therapeutics, Inc ($29,150) |
| 2018 | $31,502 | 314 | Allergan Inc. ($16,292) |
| 2017 | $26,831 | 264 | Allergan Inc. ($18,487) |
All Payment Transactions
2,219 individual payment records from CMS Open Payments — Page 1 of 89
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $1,072.83 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $38.19 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $68.57 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $65.09 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Neurology | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $15.91 | General |
| 12/06/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $138.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| 12/05/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Neuroscience | ||||||
| 11/28/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/27/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/22/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,155 | 1,677 | $409,100 | $165,306 |
| 2022 | 19 | 1,205 | 1,678 | $421,622 | $173,245 |
| 2021 | 19 | 1,194 | 1,635 | $417,509 | $175,707 |
| 2020 | 19 | 1,086 | 1,456 | $372,639 | $136,878 |
Total Patients
4,640
Total Services
6,446
Medicare Billing
$651,136
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 195 | 312 | $94,224 | $42,301 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 377 | $84,825 | $33,950 | 40.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 116 | 225 | $39,375 | $16,783 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $27,342 | $10,313 | 37.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 112 | 145 | $14,500 | $9,559 | 65.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 58 | 58 | $26,100 | $9,360 | 35.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 27 | 28 | $12,600 | $5,341 | 42.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 15 | 16 | $8,800 | $5,270 | 59.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $14,000 | $4,966 | 35.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 15 | 47 | $11,750 | $4,653 | 39.6% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 50 | 56 | $6,950 | $3,945 | 56.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 25 | 25 | $7,500 | $3,369 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 47 | $9,964 | $3,135 | 31.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 28 | 32 | $4,800 | $2,888 | 60.2% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 11 | 34 | $11,900 | $2,655 | 22.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Facility | 2023 | 12 | 25 | $9,000 | $2,351 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $6,000 | $1,595 | 26.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 26 | 81 | $16,200 | $1,211 | 7.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 25 | 28 | $2,100 | $1,207 | 57.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 16 | 18 | $1,170 | $454.14 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 224 | 326 | $98,452 | $43,491 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 420 | $94,500 | $37,744 | 39.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 119 | 236 | $41,300 | $18,503 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 93 | 93 | $40,362 | $14,719 | 36.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 46 | 46 | $20,700 | $7,694 | 37.2% |
About Dr. Mark Klafter, D.O
Dr. Mark Klafter, D.O is a Neurology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730161639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Klafter, D.O has received a total of $272,905 in payments from pharmaceutical and medical device companies, with $36,487 received in 2024. These payments were reported across 2,219 transactions from 79 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($196,437).
As a Medicare-enrolled provider, Klafter has provided services to 4,640 Medicare beneficiaries, totaling 6,446 services with total Medicare billing of $651,136. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Orlando, FL
- Active Since 11/16/2005
- Last Updated 10/28/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1730161639
Products in Payments
- BOTOX (Biological) $101,170
- NUPLAZID (Drug) $60,421
- INBRIJA (Drug) $31,460
- AJOVY (Drug) $15,213
- AJOVY (Biological) $11,005
- BOTOX (Drug) $9,511
- BOTOX NEURO REHAB (Drug) $9,037
- ONZETRA Xsail (Drug) $4,250
- AUBAGIO (Drug) $1,862
- TYSABRI (Biological) $713.11
- UPLIZNA (Drug) $645.99
- XYWAV (Drug) $637.34
- SOLIRIS (Drug) $628.15
- KESIMPTA (Drug) $610.82
- Aimovig (Biological) $588.38
- LEMTRADA (Drug) $536.44
- Neupro (Drug) $528.31
- RYTARY (Drug) $501.66
- APTIOM (Drug) $498.22
- ACTHAR (Biological) $483.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Orlando
Dr. Ramon Rodriguez-Cruz, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Amparo Gutierrez, Md, MD
Neurology — Payments: $785,842
Neurology $785,842
Dr. Nicholas Avgeropoulos, Md, MD
Neurology — Payments: $161,837
Neurology $161,837
Dr. Herbert Newton, M.d, M.D
Neurology — Payments: $105,226
Neurology $105,226
Mr. Danish Bhatti, Mbbs, MBBS
Neurology — Payments: $93,560
Neurology $93,560
Fernando Gonzales-Portillo, Md, MD
Neurology — Payments: $42,248
Neurology $42,248